PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients
Public ClinicalTrials.gov record NCT00440466. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-label, Multicenter Study of Epoetin Alfa Comparing Two Extended Dosing Regimens, Once-every-two-weeks and Once-every-four-weeks, With the Once-weekly Dosing Regimen for Maintenance Treatment in Anemic Subjects With Chronic Kidney Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate that once every-2-weeks and once every-4-weeks treatment with epoetin alfa, a drug that increases red blood cell production, in patients with anemia associated with chronic kidney disease, is not less effective than treatment with epoetin alfa that is given once a week
Study identification
- NCT ID
- NCT00440466
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 430 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2007 (Type not available)
- Primary completion
- Mar 2009 (Actual)
- Completion
- Mar 2009 (Actual)
- Last update posted
- Apr 21, 2014
2007 – 2009
United States locations
- U.S. sites
- 66
- U.S. states
- 21
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Chula Vista | California | — | — |
| Not listed | Fountain Valley | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Lynwood | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | San Dimas | California | — | — |
| Not listed | West Hills | California | — | — |
| Not listed | Yuba City | California | — | — |
| Not listed | Lakewood | Colorado | — | — |
| Not listed | Thornton | Colorado | — | — |
| Not listed | Washington D.C. | District of Columbia | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Plantation | Florida | — | — |
| Not listed | Springhill | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Zephyrhills | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Macon | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Evergreen Park | Illinois | — | — |
| Not listed | Peoria | Illinois | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | Methuen | Massachusetts | — | — |
| Not listed | Plymouth | Massachusetts | — | — |
| Not listed | Springfield | Massachusetts | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Flint | Michigan | — | — |
| Not listed | Picayune | Mississippi | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Great Neck | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Springfield Gardens | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Greenville | North Carolina | — | — |
| Not listed | Monroe | North Carolina | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Maumee | Ohio | — | — |
| Not listed | Allentown | Pennsylvania | — | — |
| Not listed | Doylestown | Pennsylvania | — | — |
| Not listed | Erie | Pennsylvania | — | — |
| Not listed | Lancaster | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Wynnewood | Pennsylvania | — | — |
| Not listed | Providence | Rhode Island | — | — |
| Not listed | Bamberg | South Carolina | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Orangeburg | South Carolina | — | — |
| Not listed | Rock Hill | South Carolina | — | — |
| Not listed | Sumter | South Carolina | — | — |
| Not listed | Arlington | Texas | — | — |
| Not listed | Fountain Valley | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Longview | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Fairfax | Virginia | — | — |
| Not listed | Hampton | Virginia | — | — |
| Not listed | Petersburg | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00440466, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2014 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00440466 live on ClinicalTrials.gov.